Novartis
About
Novartis is a Swiss-based global medicines company, and its Cambridge operation is part of the Kendall Square life sciences community. The company’s tagline is Reimagining medicine, together, and it describes its work as pursuing scientific breakthroughs for people and turning innovations into medicines for the toughest challenges in healthcare. Its portfolio has historically included innovative medicines, generic pharmaceuticals, vaccines, diagnostic tools and consumer health products.
Novartis was formed in 1996 through the merger of Ciba-Geigy and Sandoz, and it traces its scientific roots back about 250 years to the chemical industry of Basel, Switzerland, where it is still headquartered. Its history includes work on targeted therapy, which one employee describes as a completely new way of tackling cancer. Recent news includes FDA approval of remibrutinib, sold as Rhapsido, for symptomatic dermographism.
What to Know
- Recent research updates have covered multiple sclerosis and chronic spontaneous urticaria.
- Novartis publishes quarterly financial results, an annual report and a separate report on nonfinancial matters.
- Its chair co-signed an open letter with leaders of AstraZeneca, GSK, Roche, Sanofi and other drugmakers on pharmaceutical investment in Europe.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.